-
Economic Valuation of Premature COVID-19 Mortality in Kuwait: A Comparative Analysis of Three Methodological Approaches
Sep 9, 2025, 16:22 PM -
Evaluating the Impact of Subsequent Anticancer Therapy Use on Life-Year and QALY Estimates in Late-Line Metastatic Colorectal Cancer: A Health Economic Analysis of FRESCO-2
Sep 9, 2025, 16:22 PM -
What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?
Sep 9, 2025, 16:22 PM -
A Disease Progression Model Comparing Respiratory and Motor Decline in People With Late-Onset Pompe Disease Treated With Cipaglucosidase Alfa Plus Miglustat vs. Alglucosidase Alfa
Sep 9, 2025, 16:22 PM -
Evaluation of Participation Data in the Context of Cancer Prevention
Sep 9, 2025, 16:22 PM -
Understanding Treatment Preference Heterogeneity in Psoriasis: Insights From a Qualitative Analysis of Social Media Data
Sep 9, 2025, 16:22 PM -
Let LAMBA Do the Work: Can We Reduce Reliance on VBA in Health Economic Models?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients With Treatment Failure After C5 Inhibitor Therapy: An Analysis From the Brazilian Public Healthcare System Perspective
Sep 9, 2025, 16:22 PM -
Randomized Controlled Trials (RCTs) Are the Gold Standard: Are They Always Used?
Sep 9, 2025, 16:22 PM -
Prevalence of Migraine in India: A Meta-Analysis Based on Diagnostic Criteria and Gender Differences
Sep 9, 2025, 16:22 PM -
Bridging the Gap: How Early Access Shapes Pricing and Reimbursed Populations in France
Sep 9, 2025, 16:22 PM -
Applying the Evidence-Generation Continuum Concept to Support Patient Access to Innovative Therapies in France: A Use Case in Rare Diseases
Sep 9, 2025, 16:22 PM -
The Impact of Inhaler Technique on the Health Outcomes and Cost Among Adults With Asthma and Chronic Obstructive Pulmonary Disease in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Assessing the Clinical Impact of Decreasing Weight in Young Adults Using the Metabo-Reno-Cardiovascular Disease Model©
Sep 9, 2025, 16:22 PM -
Methodological Challenges for the Economic Evaluation of Genomic Newborn Screening: A Scoping Review
Sep 9, 2025, 16:22 PM -
Rescaled Tariff Regression for EQ-5D-5L Health State Valuation: An Equivalent Alternative to the Nonparametric Crosswalk
Sep 9, 2025, 16:22 PM -
Adapting HTA Frameworks for Precision Medicine: Methodological Advances in the UK and EU4
Sep 9, 2025, 16:22 PM -
Assessing Readiness for the EU-HTA Regulation: Insights From Market Access Experts Across Europe
Sep 9, 2025, 16:22 PM -
Review of Patient Decision Aids for Psoriasis
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Pegunigalsidase Alfa Compared to Agalsidase Alfa and Agalsidase Beta for the Treatment of Adult Patients With Fabry Disease in Greece
Sep 9, 2025, 16:22 PM
